Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies

The main binding site for SARS-COV-2 spike protein in human body is human Angiotensin converting enzyme 2 (ACE2) protein receptor. Herein we present the effect of chloroquine (CLQ) on human ACE2 receptor. Molecular docking studies showed that chloroquine have a docking score is quite high compare to...

Descripción completa

Detalles Bibliográficos
Autores principales: Baildya, Nabajyoti, Ghosh, Narendra Nath, Chattopadhyay, Asoke P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831893/
https://www.ncbi.nlm.nih.gov/pubmed/33518803
http://dx.doi.org/10.1016/j.molstruc.2021.129891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831893/
https://www.ncbi.nlm.nih.gov/pubmed/33518803
http://dx.doi.org/10.1016/j.molstruc.2021.129891

Ejemplares similares